Future investigations addressing isoform specificity, direct hormonal sensing, and human genetic relevance will be essential to evaluate BNC2 as a therapeutic target for obesity and related metabolic disorders. This evidence concerns the gene BNC2 and obesity due to melanocortin 4 receptor deficiency.